期刊名称：GENOME MEDICINE ISSN： 1756-994X 出版频率： Continuous publication 出版社： BMC, CAMPUS, 4 CRINAN ST, LONDON, ENGLAND, N1 9XW   出版社网址： http://www.biomedcentral.com/ 期刊网址： http://genomemedicine.com/ 影响因子： 11.117 主题范畴： GENETICS & HEREDITY 变更情况： 期刊简介(About the journal)    投稿须知(Instructions to Authors)    编辑部信息(Editorial Board)    About the journal Medicine in the post-genomic era Genome Medicine publishes peer-reviewed research articles, new methods and software tools in all areas of medicine studied from a post-genomic perspective. The journal also provides review and comment on the latest advances in translational genomics and personalized medicine, and their implications for the clinical and ethical management of human health and disease. Editor Rebecca Furlong, PhD About Genome Medicine Aims and scope | Editorial team | Open access | Article-processing charges | Indexing services | Publication and peer review process | Editorial policies | Citing articles in Genome Medicine | Why publish your article in Genome Medicine? This page includes information about the aims and scope of Genome Medicine, editorial policies, open access and article-processing charges, the peer review process and other information. For details of how to prepare and submit a manuscript through the online submission system, please see the instructions for authors. Aims & scope Genome Medicine publishes peer-reviewed research articles, new methods and software tools in all areas of medicine studied from a post-genomic perspective. The journal also provides review and comment on the latest advances in translational genomics and personalized medicine, and their implications for the clinical and ethical management of human health and disease. Editorial team Editor Rebecca Furlong Senior Editor Maria Hodges Reviews Editor Romina Andrew Assistant Editors Ripudaman Bains Andreia Cunha Editorial Assistant Clodagh McGuire Open access All Research, Case reports, Databases, Methods, Open debates and Software articles published by Genome Medicine are made freely and permanently accessible online immediately upon publication, without subscription charges or registration barriers. Further information about open access can be found here. In addition, the journal also publishes reviews and other article types that are only available by subscription. Authors of Research, Case reports, Databases, Methods, Open debates and Software articles published in Genome Medicine are the copyright holders of their articles and have granted to any third party, in advance and in perpetuity, the right to use, reproduce or disseminate the article, according to the BioMed Central copyright and license agreement. For authors who are US government employees or are prevented from being copyright holders for similar reasons, BioMed Central can accommodate non-standard copyright lines. Please contact us if further information is needed. Other content In addition to research articles Genome Medicine also publishes Research highlights, Comments, Meeting reports, Musings, Opinions, Q&As and Reviews all of which are only available by subscription. BioMed Central holds the copyright to such subscription content according to the terms of BioMed Central's Copyright Licensing Agreement. Article-processing charges Open access publishing is not without costs. Genome Medicine therefore levies an article-processing charge of £1695/$2770/€2040 for each Research, Case reports, Databases, Methods, Open debates and Software article accepted for publication. We routinely waive charges for authors from low-income countries. Generally, if the submitting author's institution is a Member the cost of the article-processing charge is covered by the membership, and no further charge is payable. In the case of authors whose institutions are Supporter Members, however, a discounted article-processing charge is payable by the author. For further details, see our article-processing charge page. A limited number of waivers for article-processing charges are also available at the editors' discretion, and authors wishing to apply for these waivers should contact the editors. Indexing services All articles published in Genome Medicine are included in PubMed, the most widely used biomedical bibliographic database service, which is run by the US National Library of Medicine. Other bibliographic databases that index articles published in Genome Medicine include: CAS Citebase Google Scholar Index Copernicus OAIster PubMed PubMed Central Science Citation Index SCImago Scirus Scopus SOCOLAR Zetoc The full text of all research articles is deposited in PubMed Central, the US National Library of Medicine's full-text repository of life science literature, and other digital archives including e-Depot (The Netherlands). Genome Medicine is tracked by Thomson Reuters (ISI) and has an Impact Factor of 3.91. Publication and peer review process Suitability of research for publication in Genome Medicine is dependent primarily on the scientific validity and coherence of the work, as well as broad interest, as assessed by reviewers and Editors. Although Genome Medicine will not make general interest level an absolute criterion for publication, it aims to provide its readership with the highest quality research and information in genomic and post-genomic medicine, and will therefore focus on articles of general and outstanding interest. All submitted research papers are subject to immediate rapid screening by the editors, in consultation with the Editorial Board if appropriate, to ensure they fall within the scope of the journal. Contributors who are in doubt about the suitability of their paper are welcome to send a presubmission enquiry. The editors will provide an initial response to all presubmission enquiries and submitted articles within five working days. Manuscripts will be reviewed by internationally recognized experts in the fields of genomic and post-genomic medicine selected in part from our Editorial Board. Genome Medicine operates an anonymous peer review process. Reviews will be rapid and the suitability of a paper for publication will be assessed solely on criteria of scientific excellence. The editors will make every effort to give authors a decision following peer review within four weeks of an article's submission. Articles are published electronically as promptly as possible after they are accepted, and within one month of acceptance. Authors will be able to check the progress of their manuscript through the submission system at any time by logging into My Genome Medicine, a personalized section of the site. Copyediting and proofs All articles published in Genome Medicine are copyedited before publication of the final version. Research, Case reports, Databases, Methods, Open debates and Software articles published in Genome Medicine are published immediately on acceptance in the form of a provisional PDF. Copyedited and fully formatted PDF and full-text (HTML) versions are made available shortly after that. Edited versions will be sent by email and corrections should be returned within two working days. Please provide a typed list of corrections clearly indicating where the corrections should be made and please send this list by email. The editing of Research, Case reports, Databases, Methods, Open debates and Software articles is designed only to correct such things as misused words, spelling errors, missing references or incomplete citation information. Reprints High-quality, bound reprints can be purchased for all articles published. Please see our reprints website for further information about ordering reprints. Supplements Genome Medicine will consider supplements based on proceedings (full articles or meeting abstracts), reviews or research. All articles submitted for publication in supplements are subject to peer review. Published supplements are fully searchable and freely accessible online and can also be produced in print. All full length articles (proceedings, reviews or research articles) are indexed by PubMed. PubMed displays the title of the supplement only in the case of meeting abstract collections. For further information, please contact us. Editorial policies All manuscripts submitted to Genome Medicine should adhere to BioMed Central's editorial policies. Citing articles in Genome Medicine Articles in Genome Medicine should be cited in the same way as articles in a traditional journal. Because articles are not printed, they do not have page numbers; instead, they are given a unique article number. Article citations follow this format: Authors: Title. Genome Med [year], [volume number]:[article number]. e.g. Roberts LD, Hassall DG, Winegar DA, Haselden JN, Nicholls AW, Griffin JL: Increased hepatic oxidative metabolism distinguishes the action of Peroxisome Proliferator-Activated Receptor delta from Peroxisome Proliferator-Activated Receptor gamma in the Ob/Ob mouse. Genome Med 2009, 1:115. refers to article 115 from Volume 1 of the journal. Why publish your article in Genome Medicine? High visibility Genome Medicine's open access policy allows maximum visibility of research articles published in the journal as they are available to a wide, global audience. Articles that have been especially highly accessed are highlighted with a 'Highly accessed' graphic, which appears on the journal's contents pages and search results. Speed of publication Genome Medicine offers a fast publication schedule whilst maintaining rigorous peer review; all articles must be submitted online, and peer review is managed fully electronically (articles are distributed in PDF form, which is automatically generated from the submitted files). Articles are published with their final citation immediately upon acceptance in a provisional PDF form. The article will subsequently be published in both fully browsable web form, and as a formatted PDF; the article will then be available through Genome Medicine, BioMed Central and PubMed Central and will also be included in PubMed. Flexibility Online publication in Genome Medicine gives authors the opportunity to publish large datasets, large numbers of color illustrations and moving pictures, to display data in a form that can be read directly by other software packages so as to allow readers to manipulate the data for themselves, and to create all relevant links (for example, to PubMed, to sequence and other databases, and to other articles). Promotion and press coverage Articles published in Genome Medicine are included in article alerts and regular email updates. Some may be included in abstract books mailed to academics and are highlighted on Genome Medicine's pages and on the BioMed Central homepage. In addition, articles published in Genome Medicine may be promoted by press releases to the general or scientific press. These activities increase the exposure and number of accesses for articles published in Genome Medicine. A list of articles recently press-released by journals published by BioMed Central is available here. Copyright Authors of research articles published in Genome Medicine retain the copyright of their articles and are free to reproduce and disseminate their work (for further details, see the BioMed Central copyright and license agreement). For further information about the advantages of publishing in a journal from BioMed Central, please click here.   Instructions to Authors Instructions for authors Genome Medicine publishes peer-reviewed research articles, new methods and software tools in all areas of medicine studied from a post-genomic perspective. The journal also provides review and comment on the latest advances in translational genomics and personalized medicine, and their implications for the clinical and ethical management of human health and disease. Each article type published by Genome Medicine follows a specific format, as detailed in the corresponding instructions for authors; please choose an article type from the list on the left to view the instructions for authors. Please note that Research highlight, Comment, Correspondence, Letter to the editor, Meeting report, Musings, Opinion, Q&A and Review are usually commissioned, but suggestions for these article types are welcome. The instructions for authors includes information about preparing a manuscript for submission to Genome Medicine, criteria for publication and the online submission process. Other relevant information about the journal's policies, the refereeing process and so on can be found in 'About this journal'. Presubmission enquiries If you wish to make a presubmission enquiry about the suitability of your manuscript, please email the editors who will respond to your enquiry as soon as possible. Genome Medicine publishes the following article types: Research Research highlights Case reports Comments Correspondence Databases Letters to the editor Meeting reports Methods Musings Open debates Opinions Q&As Reviews Software We use plagiarism detection This journal is a member of, and subscribes to the principles of, the Committee on Publication Ethics (COPE). Authors and referees are asked to declare any competing interests. Copyright for research articles rests with the authors. For more information on copyright of research articles, see our publisher's copyright and license policy. Copyright of all other articles rests with the publisher, BioMed Central. Editorial Board Editorial team Editor Rebecca Furlong Senior Editor Maria Hodges Reviews Editor Romina Andrew Assistant Editors Ripudaman Bains Andreia Cunha Editorial Assistant Clodagh McGuire Editorial Board Section Editor 1. Genomics & epigenomics of disease James R Lupski Baylor College of Medicine, USA 2. Pharmacogenomics & personalized medicine Matthias Schwab University of Tuebingen, Germany 3. Genomic epidemiology & public health genomics Muin J Khoury Centers for Disease Control and Prevention, USA 4. Proteomics & metabolomics in medicine Timothy D Veenstra National Cancer Institute at Frederick, USA 5. Systems medicine & informatics Charles Auffray Centre National de la Recherche Scientifique, France 6. Ethical, legal & social issues Timothy Caulfield University of Alberta, Canada Editorial board Russ Altman Stanford University, USA David Balding University College London, United Kingdom Stephan Beck University College London, United Kingdom Juergen Borlak Hannover Medical School, Germany Carl Borrebaeck Lund University, Sweden Atul Butte Stanford University, USA George Calin MD Anderson Cancer Center, USA Nigel Carter The Sanger Institute, United Kingdom Richard Christopherson University of Sydney, Australia Angus Clarke Cardff University, United Kingdom J Craig Cohen Alabama College of Osteopathic Medicine, USA David Cooper Cardiff University, United Kingdom Ann Daly Newcastle University, United Kingdom Paul Edwards Cambridge University, United Kingdom Charis Eng Cleveland Clinic, USA Xavier Estivill Center for Genomic Regulation, Spain Gary Gibbons National Heart, Lung, and Blood Institute, USA Greg Gibson Georgia Institute of Technology, USA Takashi Gojobori National Institute of Genetics, Japan Julian Griffin University of Cambridge, United Kingdom Sean Grimmond University of Queensland, Australia David Gurwitz Tel-Aviv University, Israel Brian Haab Van Andel Institute, USA Samir Hanash Fred Hutchinson Cancer Research Center, USA Albert Heck Utrecht University, Netherlands Matthew Henn Seres Health, Cambridge, USA Martin Hibberd Genome Institute of Singapore, Singapore Winston Hide Harvard School of Public Health, USA Tasuku Honjo Kyoto University Graduate School of Medicine, Japan Leroy Hood Institute for Systems Biology, USA Matthew Hurles Wellcome Trust Sanger Institute, United Kingdom Ravi Iyengar Mount Sinai School of Medicine, USA A Cecile Janssens Emory University, USA Dr Rima Kaddurah-Daouk Duke University Medical Center, USA Douglas Kell UMIST, United Kingdom Bartha Knoppers Université de Montréal, Canada Isaac Kohane Children's Hospital Boston, USA Doron Lancet Weizmann Institute of Science, Israel Lance Liotta NIH, USA Edison Liu The Jackson Laboratory, USA Nuria Lopez-Bigas University Pompeu Fabra and ICREA, Spain David Lubman University of Michigan, USA Jeantine Lunshof VU University Amsterdam, Netherlands, and Harvard Medical School, USA Simon Mallal Murdoch University, Australia Elaine Mardis Washington University School of Medicine, USA Stephen Marx National Institute of Diabetes and Digestive and Kidney Diseases, USA Mark McCarthy Oxford University, United Kingdom Amy McGuire Baylor College of Medicine, USA Aleksandar Milosavljevic Baylor College of Medicine, USA Joyce Mitchell University of Utah, USA Yves Moreau University of Leuven, Belgium Yusuke Nakamura University of Chicago, USA Jeremy Nicholson Imperial College London, United Kingdom Robert Nussbaum University of California, San Francisco, USA Stuart Orkin Harvard Medical School, USA Margaret Pericak-Vance University of Miami, USA Emanuel Petricoin George Mason University, USA Munir Pirmohamed The University of Liverpool, United Kingdom Alexandre Reymond University of Lausanne, Switzerland H Hilger Ropers Max-Planck Institute for Molecular Genetics, Germany Charles Rotimi National Institutes of Health, USA Stephen Scherer Hospital for Sick Children, Canada Nicholas Schork The Scripps Research Institute, USA James Scott Imperial College London, United Kingdom Richard Smith Pacific Northwest National Laboratory, USA Nicole Soranzo Wellcome Trust Sanger Institute, United Kingdom Constantine Stratakis National Institute of Child Health & Human Development, USA Visith Thongboonkerd Mahidol University, Thailand Lap-Chee Tsui University of Hong Kong Toshikazu Ushijima National Cancer Center Research Institute, Japan Joris Veltman UMC Nijmegen, Netherlands Marc Vidal Dana-Farber Cancer Institute, USA Peter Visscher University of Queensland, Australia Scott Weiss Brigham and Women's Hospital, USA C Roland Wolf University of Dundee, United Kingdom Alan Wright MRC Human Genetics Unit, United Kingdom Jingde Zhu Shanghai Jiaotong University, China